Clinical Trials · NCT00355030
Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 91
- Start date
- Jun 2006
- Locations
- 19 sites, France, Netherlands
- Primary endpoint
- Number of Participants With One or More Drug-related Adverse Events